474P - A phase I study to determine the effect of regorafenib (REG) on the pharmacokinetics (PK) of substrates of P-glycoprotein (P-gp; digoxin) and breast cancer resistant protein (BCRP; rosuvastatin) in patients with advanced solid tumors
| Autor: | Strumberg, D., Al-Batran, S.-E., Takacs, I., Géczi, L., Cleton, A., Huang, F., Mueller, U., Graudenz, K., Trnkova, Z., Sturm, I. |
|---|---|
| Zdroj: | In Annals of Oncology 1 October 2016 27 Supplement 6:vi156-vi156 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|